comparemela.com

Latest Breaking News On - Shilpa medicare - Page 10 : comparemela.com

Valuations: Stagger out your investments over the next few weeks: Jyotivardhan Jaipuria

Yes, on the margin we have actually built some cash which we did not have earlier. So, in most portfolios, we are now sitting between 5% and 10% cash.

Poor quality: Lens on Indian drugs

smallcap stock gainers: 52 smallcap stocks offer double-digit returns in record-breaking week for markets

Equity markets in India reached new records in the last week of June, ending the month with a 3.5% gain. The rally was supported by strong foreign institutional investor flow and positive sentiment from the advance of the southwest monsoon. Several smallcap and midcap stocks delivered double-digit returns. Analysts expect the upward trend to continue, and investors will be watching for economic data releases and insights from the US Federal Reserve s FOMC minutes going ahead.

Shilpa Medicare Limited Launches Lenvatinib Capsules (12mg, 18 mg and 24 mg) in India under the brand name Lenshil®

Shilpa Medicare Limited Launches Lenvatinib Capsules (12mg, 18 mg and 24 mg) in India under the brand name Lenshil®
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Shilpa Medicare Limited approves rights issue

Shilpa Medicare Limited approves rights issue
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.